Embolic Agent Articles & Analysis: Older
3 news found
Balt announced today that the first patients have been enrolled in the clinical trial; The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic subdural hematoma [NCT04410146]. This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for the ...
Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma. ...
University of Minnesota researchers have developed embolic agents that can be absorbed by the body after the therapeutic treatment has been obtained. ...